BioHarvest Sciences (NASDAQ:BHST – Get Free Report) and Nu Skin Enterprises (NYSE:NUS – Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.
Analyst Ratings
This is a summary of current ratings for BioHarvest Sciences and Nu Skin Enterprises, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BioHarvest Sciences | 1 | 0 | 1 | 0 | 2.00 |
| Nu Skin Enterprises | 1 | 1 | 0 | 0 | 1.50 |
BioHarvest Sciences currently has a consensus price target of $10.00, indicating a potential upside of 362.96%. Given BioHarvest Sciences’ stronger consensus rating and higher possible upside, equities analysts plainly believe BioHarvest Sciences is more favorable than Nu Skin Enterprises.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| BioHarvest Sciences | -32.54% | -76.03% | -25.30% |
| Nu Skin Enterprises | 3.78% | 7.47% | 4.21% |
Volatility and Risk
BioHarvest Sciences has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.
Institutional & Insider Ownership
82.8% of Nu Skin Enterprises shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares BioHarvest Sciences and Nu Skin Enterprises”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BioHarvest Sciences | $34.51 million | 1.23 | -$11.14 million | ($0.59) | -3.66 |
| Nu Skin Enterprises | $1.49 billion | 0.17 | $160.20 million | $1.10 | 4.71 |
Nu Skin Enterprises has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.
Summary
Nu Skin Enterprises beats BioHarvest Sciences on 10 of the 14 factors compared between the two stocks.
About BioHarvest Sciences
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
